We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+6.14%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$12.7B
AUM Growth
+$669M
Cap. Flow
+$101M
Cap. Flow %
0.79%
Top 10 Hldgs %
53.96%
Holding
1,032
New
51
Increased
303
Reduced
597
Closed
72

Sector Composition

Rank Sector Weight
1 Energy 65.53%
2 Technology 4.85%
3 Healthcare 3.53%
4 Consumer Discretionary 3.46%
5 Financials 3.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RBLX icon
501
Roblox
RBLX
$34.7B
$927K 0.01%
20,267
-9,312
-31% -$344K
MAR icon
502
Marriott International
MAR
$101B
$921K 0.01%
4,084
-399
-9% -$80.9K
PTGX icon
503
Protagonist Therapeutics
PTGX
$8.77B
$919K 0.01%
40,072
-2,377
-6% -$41.6K
EOG icon
504
EOG Resources
EOG
$75.3B
$918K 0.01%
7,592
-516
-6% -$64.2K
GEVO icon
505
Gevo
GEVO
$382M
$917K 0.01%
790,809
-133,572
-14% -$152K
IDA icon
506
Idacorp
IDA
$8.2B
$912K 0.01%
9,277
+1,280
+16% +$124K
SKT icon
507
Tanger
SKT
$4.8B
$906K 0.01%
32,681
-2,080
-6% -$51.8K
AUPH icon
508
Aurinia Pharmaceuticals
AUPH
$1.99B
$904K 0.01%
100,524
-5,287
-5% -$43.5K
LSXMA
509
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$897K 0.01%
+31,200
New +$817K
ARCT icon
510
Arcturus Therapeutics
ARCT
$164M
$890K 0.01%
28,220
-2,103
-7% -$50K
AMSF icon
511
AMERISAFE
AMSF
$560M
$884K 0.01%
18,894
+2,662
+16% +$133K
REYN icon
512
Reynolds Consumer Products
REYN
$5.4B
$876K 0.01%
32,637
+4,608
+16% +$120K
DAWN
513
DELISTED
Day One Biopharmaceuticals
DAWN
$872K 0.01%
59,695
-4,458
-7% -$54K
AKRO
514
DELISTED
Akero Therapeutics
AKRO
$869K 0.01%
37,232
-3,776
-9% -$74.5K
MPT
515
Medical Properties Trust
MPT
$2.9B
$866K 0.01%
176,406
+9,106
+5% +$44.6K
FNB icon
516
FNB Corp
FNB
$6.74B
$866K 0.01%
62,871
-3,810
-6% -$45.1K
ROKU icon
517
Roku
ROKU
$21.2B
$857K 0.01%
9,346
-2,683
-22% -$224K
XNCR icon
518
Xencor
XNCR
$1.48B
$854K 0.01%
40,224
-4,479
-10% -$85.2K
AGIO icon
519
Agios Pharmaceuticals
AGIO
$2.24B
$843K 0.01%
37,844
-3,255
-8% -$72.9K
EXPD icon
520
Expeditors International
EXPD
$22.4B
$842K 0.01%
6,616
+33
+0.5% +$3.89K
DIS icon
521
Walt Disney
DIS
$168B
$833K 0.01%
9,229
-105
-1% -$9.26K
BCRX icon
522
BioCryst Pharmaceuticals
BCRX
$2.47B
$827K 0.01%
138,101
-1,749
-1% -$10.1K
NFG icon
523
National Fuel Gas
NFG
$7.71B
$825K 0.01%
16,435
+2,304
+16% +$119K
HSY icon
524
Hershey
HSY
$36.5B
$824K 0.01%
4,419
+21
+0.5% +$3.98K
MVST icon
525
Microvast
MVST
$265M
$823K 0.01%
588,168
-78,052
-12% -$105K

Similar funds

ALPS Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, ALPS Advisors held 1,032 positions worth $12.7B, up 5.5% from $12B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

ALPS Advisors's Q4 2023 filing shows 51 new, 303 increased, 597 reduced and 72 closed positions. Its largest new stake was Sunoco: 9,498,706 shares worth $569M. The largest sale was Crestwood Equity Partners LP, an estimated $443M.

By sector, the portfolio is most concentrated in Energy at 66% of assets, down from 68% a quarter earlier, followed by Technology and Healthcare.

  • ALPS Advisors's largest Q4 2023 buy was Sunoco: 9,498,706 shares worth $569M.
  • ALPS Advisors added most to Cameco in Q4 2023, an estimated $34.4M increase.
  • ALPS Advisors's biggest Q4 2023 reduction was MPLX, cutting an estimated $114M.
  • ALPS Advisors fully exited Crestwood Equity Partners LP in Q4 2023, selling an estimated $443M.
  • ALPS Advisors's ten largest holdings make up 54% of its $12.7B portfolio in Q4 2023.
  • ALPS Advisors opened 51 new positions and closed 72 in Q4 2023.
  • ALPS Advisors's portfolio value rose 5.5% quarter-over-quarter to $12.7B.

Based on ALPS Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.